The sex
These results suggest that in chicken, IGF-I mRNA is expressed in liver in a GH-dependent manner after hatching, whereas in other tissues, mRNA expression is independent of GH and GHR before and after hatching, except for testis, in which GH seems to inhibit IGF-I mRNA expression. (Endocrinology 137: 30-34, 1996) I NSULIN-LIKE growth factor I (IGF-I) is involved in the promotion of growth and differentiation of a variety of vertebrate tissues (1, 2). In mammals, the major source of serum IGF-I is known to be liver, where IGF-I synthesis is stimulated by binding of GH to its specific receptor. The growth-promoting effect of GH is, therefore, considered to be dominantly mediated by IGF-I synthesized in liver (3-5). IGF-I has also been shown to be expressed at lower levels in certain extrahepatic tissues of rat, with some degree of GH dependence (6-10). In chicken, IGF-I messenger RNA (mRNA) expression has been demonstrated in adult liver, muscle, brain, and heart (11) and in embryonic muscle, brain, and eye (12). Leung et al. (13) observed an increase in the serum IGF-I concentration in Hubbard cockerels after administration of chicken GH, whereas in broiler chicken, exogenous GH administration had no effect on the serum IGF-I level (14) . Furthermore, it was demonstrated that in chickens, the serum IGF-I concentration is not correlated with the serum GH level during embryonic development (12) or during the posthatching period (12, 15) . Thus, the mechanism of IGF-I induction in chicken tissues has not yet been clearly elucidated.
The sex-linked dwarfism in chicken has been shown to result from deficiencies in GH receptor (GHR) (16) (17) (18) (19) (20) (21) , and it provides an excellent system to investigate the GH depen-dence of IGF-I production in tissues. Recently, we reported the presence of a point mutation of T to C at the exon 5/intron 5 junction, changing the 5'-end of the intron region from GT to GC, in the GHR gene on the Z-chromosome of a sex-linked dwarf (SLD) chicken, Gifu 20 (22, 23) . This mutation has caused an inappropriate splicing of the GHR gene transcript and the failure of GHR protein synthesis, probably because of an aberrant stop codon created in the midst of the extracellular domain (23). Interestingly, despite the absence of GHR in whole tissues of this SLD chicken, IGF-I is secreted into plasma (22) at levels reaching about 30% of those in normal control chickens (our unpublished data). In other lines of SLD chickens, similarly decreased concentrations of plasma IGF-I have been reported (24, 25) . These findings have prompted us to investigate whether plasma IGF-I in chicken is derived from tissues in which the factor is synthesized independently of the GH action.
We report here that in the GHR-deficient dwarf chicken, IGF-I mRNA expression in extrahepatic tissues is not reduced, whereas hepatic IGF-I expression is completely abolished.
Materials
and Methods The radiolabeled RNA probe (1 X lo5 cpm/assay) was hybridized with 20 pg total RNA at 50 C for 16 h in 30 ~1 of a solution containing 40 mM piperazine-iV,N'-bis(2-ethanesulfonic acid) (PIPES) (pH 6.5),0.4 M NaCI, 1 mM EDTA, and 80% formamide.
Animals
The amounts of intact RNA input were confirmed to be equivalent by the bands of 28 and 185 ribosomal RNAs. The hybridized RNA samples were then digested with RNase A (40 pg/ml) and RNase Tl (2 pg/ml) at 30 C for 30 min, and the samples were incubated with proteinase K (50 pg/ml) at 37 C for 15 min. The protected RNA fragments were separated by electrophoresis in a 6% polyacrylamide-7 M urea gel. The amounts of 286-bp protected fragments were quantitatively determined by a Fuji BASS 1000 imaging analyzer (Fuji Photo Film Co., Tokyo, Japan).
Results
Northern blot analysis of GHR mRNA in tissues of normal and dwarf chickens Expression of GHR mRNA in tissues of normal and SLD chickens of the Gifu 20 strain was examined by Northern blot analysis. In 4-week-old chickens, the mature GHR mRNA of 4.5 kilobases (kb) (23) was detected clearly in liver, lung, testis, and muscle, and faintly in kidney, spleen, heart, intestine, thymus, and brain of normal chickens (Fig. 1A) . In dwarf chickens, intron 5-containing 5.5-kb transcripts (23) were detected in all tissues examined (Fig. 1B) . The relative abundance of the transcript among the tissues was similar to that of the 4.5-kb transcript among normal tissues. In addition to the larger transcript, aberrantly spliced 0.8kb transcripts (18,231 were observed in tissues of the SLD chicken. The smaller transcript was expressed as the major species in liver and muscle. Some other minor transcripts were also detected in the tissues of the dwarf chicken.
On day 16 in the embryonic stage, normal chicks expressed the 4.5-kb GHR mRNA in the tissues examined, with relatively higher levels in liver and muscle, whereas the dwarf chicks expressed the mutant transcripts observed in 4-weekold SLD chickens (Fig. 2) .
RNase protection assay of IGF-I mRNA in tissues of normal and dwarf chickens
We next determined mRNA expression levels for IGF-I by RNase protection assay in tissues of normal and SLD chickens, expressing the normal and mutated GHR transcripts, respectively. Figure 3 shows the autoradiograms detecting the 268-bp RNA fragments protected by IGF-I mRNA ex- pressed in tissues of normal (A) and dwarf (B) chickens at 4 weeks of age. The amounts of IGF-I mRNA were estimated by measuring the radioactivities of the protected RNA probe using a Fuji BASS 1000 imaging analyzer and expressed as relative values to those obtained for normal chicken liver (Fig. 4) . The highest level of IGF-I mRNA expression was observed in normal chicken liver, whereas no IGF-I mRNA expression was detected in dwarf chicken liver.
On the other hand, considerable levels of IGF-I mRNA (lo-30% of the value in the control liver) were expressed in spleen, lung, and brain in both normal and dwarf chickens. In testis, mRNA expression was enhanced in dwarf chickens, showing a level comparable to that in normal liver. IGF-I mRNA expression was also observed in kidney, heart, intestine, thymus, and muscle of normal and SLD chickens, but their expression levels were less than 4% of that in normal liver. Thus, in these extrahepatic tissues, no decrease in the expression level of IGF-I mRNA was observed in SLD chickens compared to that in normal chickens.
Furthermore, as shown in Figs. 5 and 6, at the day 16 embryonic stage, no IGF-I mRNA expression was detected in liver or kidney in both normal and dwarf chicks, whereas mRNA expression up to 2530% of that in liver of control 4-week-old chickens was observed in muscle, brain, and eye in both normal and dwarf chicks. Decreased expression of IGF-I mRNA was detected in heart and lung from normal and dwarf embryos.
Discussion
Daughaday et al. (27) originally formulated the somatomedin hypothesis, proposing that the effects of GH on cartilage are not due to a direct action of GH on target tissue, but are mediated through a class of peptide growth factors, designated somatomedins. Since then, many laboratories have shown that one of these factors, IGF-I, is the most likely candidate for an intermediary in the growth-promoting action of GH (1, 2). Actually, in man, serum IGF-I concentrations are higher than normal in acromegaly (28) and lower than normal in hypopituitarism (29). In rodents, exogenous GH increases plasma IGF-I levels through its binding to GHR on liver plasma membrane, indicating that the major site for FIG. 4. Relative expression levels of IGF-I mRNAin tissues of normal (closed columns) and SLD (open columns) chickens at 4 weeks of age. The values were quantitatively determined by a BASS 1000 image analyzer (Fuji Photo Film Co.) with samples from the RNase protection assay obtained from triplicate experiments. The data were expressed as a percentage of the value obtained for normal liver.
IGF-I synthesis in response to GH action is the liver (3-5).
Recent research has revealed that in addition to liver, other tissues can synthesize IGF-I, as shown in rats (7, 8) and chickens (11, 12) . However, the GH dependence of IGF-I expression in these vertebrate tissues has not been detected uniformly.
In postnatal rats, IGF-I mRNA synthesis is dependent on GH in all tissues examined (9,101, whereas remarkable IGF-I expression is observed in all embryonic tissues of the rat before the onset of GH production during midgestation (30). Similar GH-independent IGF-I expression was observed in human fetal tissues (31). In chick embryos, the ontogeny of IGF-I mRNA was similarly observed in muscle, eye, and brain before the onset of GH secretion during the midembryonic period, but in liver of chick embryos, no IGF-I mRNA was detected throughout the embryonic stage (12). The GH dependence of body weight gain and IGF-I expression in chickens after hatching has been controversial. In broiler chickens, no correlation was found between the plasma concentrations of GH and IGF-I (15), and no growth-promoting effect (32) or increase in plasma IGF-I concentration was observed after treatment with recombinant chicken GH (14). On the other hand, significantly lowered plasma IGF-I concentrations were found in hypophysectomized chickens (331, and increases in serum IGF-I concentration and body weight gain after treatment with purified chicken GH were observed in 4-week-old cockerels (13). Considering the general features of GHR-deficient SLD chickens (17), which include a mature body weight that is 30-40% lower than normal, a serum IGF-I level that is about 70% lower than normal, and shorter long bones than normal, the IGF-I production and body growth in chickens must be at least partially dependent on GH. The present study was conducted to elucidate those controversial findings on the GH dependence of IGF-I expression in chicken tissues using a GHR-deficient SLD chicken line. Normal 4-week-old chickens expressed GHR mRNA of 4.5 kb in liver and, to a lesser extent, in other tissues, such as spleen, heart, lung, intestine, testis, muscle, and brain, whereas SLD chickens of the Gifu 20 strain expressed a mutated intron-containing 5.5-kb transcript or aberrantly truncated short transcripts for GHR in these tissues. This mutation in the GHR gene was the cause of the lack of GHR in whole tissues and the dwarfism in this SLD chicken (23). The serum IGF-I concentration in chickens has been reported to increase rapidly after hatching, reaching a maximal level at 4 weeks of age (34). In 4-week-old normal chickens, the highest expression of IGF-I mRNA was observed in liver, and lesser expression of the mRNA was detected in spleen, heart, lung, intestine, testis, muscle, and brain. On the other hand, in SLD chickens, no IGF-I mRNA expression was detected in liver, as expected. This indicated that IGF-I expression in chicken liver after hatching is completely dependent on the presence of GHR and GH. The GHR dependence of IGF-I mRNA expression in chicken liver has also been demonstrated by Huang et al. (18) in cultured chicken hepatocytes.
In other tissues of the SLD chicken, however, IGF-I mRNA expression was comparable to that in corresponding tissues from normal chickens, except for testis, in which IGF-I mRNA expression was remarkably enhanced in SLD chickens. The result clearly indicated that in chicken extrahepatic tissues such as spleen, heart, lung, intestine, testis, muscle, and brain, IGF-I mRNA expression is independent of GHR or GH. Rather, in the testis of dwarf chickens, the IGF-I mRNA level was 5-fold higher than normal. In normal chicken testis, the GHR mRNA expression level was as high as that in normal liver, suggesting that IGF-I mRNA expression in normal testis might be inhibited by the action of GH. A similar inhibitory effect of GH on IGF-I gene expression has been reported in rat uterus (35). In chick embryos, IGF-I has been detected in the circulation, with maximum levels on embryonic days 14-17 (121, and IGF-I is suggested to stimulate the growth of embryo (36) and the differentiations of myoblasts (37) and lens fiber cells (38) . In the present study, day 16 embryos were shown to express IGF-I mRNA in heart, lung, muscle, brain, and eye in the presence or absence of GHR. Thus, IGF-I mRNA expression in extrahepatic tissues of chick embryos was also GHR independent.
In liver and kidney of chick embryos, on the other hand, no IGF-I mRNA expression was detected in normal or SLD chickens. Similar results in normal chick embryos have been reported by Kikuchi et al. (12) , and they showed that GH is detectable in the circulation from day 12 of the embryonic stage. We also detected a high level of expression of GHR mRNA in liver of normal chick embryos. These results suggest that the expression of IGF-I mRNA in liver of chick embryos is not sensitive to or dependent on GH. In conclusion, in chickens, IGF-I mRNA expression becomes GH dependent after hatching, presumably only in the liver.
At present, the factor(s) that stimulates the gene expression of IGF-I in extrahepatic tissues of chickens and the molecular basis for the tissue differences in GH responsiveness are not known. The chicken IGF-I gene and its 5'-promoter region have been cloned and partially characterized (39); however, the precise regulatory mechanism of IGF-I gene expression in chicken tissues is still open to investigation. The GHR-deficient SLD chickens may provide a useful system to elucidate these GH-dependent and -independent mechanisms of IGF-I gene expression in chicken tissues.
